MedTrace Logo

Study of Gesture and Executive Functions in Children With High Intellectual Potential

NCT03128125 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2020-10-05

No results posted yet for this study

Summary

The main objective of this study is to determine whether children with high intellectual potential have gestural and / or executive difficulties compared to control children.

Conditions

  • High Intellectual Potential
  • Children

Interventions

OTHER

clinical examination in neurology

This examination is based on the movement of the child in a standing position (forward and backward on a straight line, jumping on a foot ...), seated (visual continuation ...) and elongated (tone, patellar and achillian reflexes, superficial sensitivity ...) . This makes it possible to evaluate all the neurological systems.

OTHER

neuropsychological examination

This examination is based on the use of standardized psychometric tools and validated with children, usually used in clinical practice.

OTHER

anamnestic elements

Several elements will be collected during the clinical interview to inform the history of the child's development, such as neonatal data (term of pregnancy, APGAR score ...), age of appearance of the first words , seating, walking, possible care, level of education ans level of education of the parents.

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • Sylviane PEUDENIER · CHRU Brest

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-06
Primary Completion
2018-08-22
Completion
2018-08-22

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03128125 on ClinicalTrials.gov